Janus Henderson Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$79.7M Buy
1,233,658
+369,702
+43% +$26.1M 0.04% 321
2025
Q4
$58.1M Sell
863,956
-94,073
-10% -$6.33M 0.03% 384
2025
Q3
$70.3M Buy
958,029
+47,635
+5% +$3.16M 0.03% 345
2025
Q2
$47.4M Buy
910,394
+195,667
+27% +$11.1M 0.02% 398
2025
Q1
$45.6M Buy
714,727
+12,642
+2% +$734K 0.03% 397
2024
Q4
$33.6M Buy
702,085
+156,912
+29% +$8.05M 0.02% 474
2024
Q3
$31.2M Buy
545,173
+31,871
+6% +$1.83M 0.02% 489
2024
Q2
$26.9M Sell
513,302
-17,823
-3% -$782K 0.01% 510
2024
Q1
$21.6M Buy
531,125
+102,911
+24% +$3.86M 0.01% 551
2023
Q4
$15.8M Buy
428,214
+1,274
+0.3% +$48K 0.01% 588
2023
Q3
$16.3M Sell
426,940
-1,031
-0.2% -$42.2K 0.01% 574
2023
Q2
$15.4M Sell
427,971
-93
-0% -$3.17K 0.01% 602
2023
Q1
$16.3M Sell
428,064
-216,078
-34% -$10.1M 0.01% 614
2022
Q4
$36.7M Sell
644,142
-734,930
-53% -$37.6M 0.03% 441
2022
Q3
$54.5M Buy
1,379,072
+691,032
+100% +$30.5M 0.02% 495
2022
Q2
$30.3M Sell
688,040
-41,735
-6% -$1.81M 0.02% 499
2022
Q1
$29.1M Buy
729,775
+58,204
+9% +$2.07M 0.01% 657
2021
Q4
$27M Buy
671,571
+13,176
+2% +$492K 0.01% 710
2021
Q3
$26.8M Buy
658,395
+6,539
+1% +$273K 0.01% 724
2021
Q2
$29.6M Sell
651,856
-31,313
-5% -$1.39M 0.01% 692
2021
Q1
$28.5M Sell
683,169
-116,241
-15% -$5.31M 0.01% 693
2020
Q4
$34.1M Sell
799,410
-89,893
-10% -$3.23M 0.02% 631
2020
Q3
$23.4M Buy
+889,303
New +$24.8M 0.01% 677

Other funds holding HALO

Janus Henderson Group's HALO Position: Q1 2026 in Review

Janus Henderson Group increased its Halozyme (HALO) stake by 43% in Q1 2026, buying an estimated $26.1M and bringing the position to 1,233,658 shares worth $79.7M. The position accounts for 0.04% of the portfolio, ranked #321.

Janus Henderson Group first reported a position in HALO in Q3 2020 and has held it in 23 quarters since. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Janus Henderson Group held 1,233,658 shares of Halozyme worth $79.7M as of Q1 2026.
  • Janus Henderson Group bought 369,702 Halozyme shares in Q1 2026, an estimated $26.1M.
  • Halozyme made up 0.04% of Janus Henderson Group's portfolio in Q1 2026, its #321 holding.
  • Janus Henderson Group first reported a position in Halozyme in Q3 2020 and has held it in 23 quarters since.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.